Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
46
MMC Quote, Financials, Valuation and Earnings
Last price:
$210.05
Seasonality move
:
3.1%
Day range:
$210.06 - $214.05
52-week range:
$186.30 - $235.50
Dividend yield:
1.44%
P/E ratio:
26.08x
P/S ratio:
4.39x
P/B ratio:
7.60x
Volume:
2.8M
Avg. volume:
1.9M
1-year change:
14.21%
Market cap:
$104B
Revenue:
$22.7B
EPS (TTM):
$8.12
Earnings Data
Next earnings date for MMC
Jan 24
2025
Most recent earnings per share
$1.51
Missed by $0.11
(Oct 17/2024)
Consensus Estimate
$1.62
(Oct 17/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MMC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 01/24/2025 | Q4 | $5.9B | -- | -- | $1.78 | -- |
| 10/17/2024 | Q3 | $5.7B | $5.7B | $1.51 | $1.62 | -$0.11 |
| 07/18/2024 | Q2 | $6.3B | $6.2B | $2.27 | $2.39 | -$0.12 |
| 04/18/2024 | Q1 | $6.4B | $6.5B | $2.82 | $2.80 | $0.02 |
| 01/25/2024 | Q4 | $5.5B | $5.6B | $1.52 | $1.63 | -$0.11 |
| 10/19/2023 | Q3 | -- | -- | $1.47 | $1.39 | $0.08 |
| 07/20/2023 | Q2 | -- | -- | $2.07 | $2.12 | -$0.05 |
| 04/20/2023 | Q1 | -- | -- | $2.47 | $2.47 | -$0.00 |
| 01/26/2023 | Q4 | -- | -- | $0.93 | $1.41 | -$0.48 |
| 10/20/2022 | Q3 | -- | -- | $1.08 | $1.14 | -$0.06 |
| 07/21/2022 | Q2 | -- | -- | $1.91 | $1.86 | $0.05 |
| 04/21/2022 | Q1 | -- | -- | $2.10 | $2.14 | -$0.04 |
| 01/27/2022 | Q4 | -- | -- | $1.57 | $1.35 | $0.22 |
| 10/21/2021 | Q3 | -- | -- | $1.05 | $1.00 | $0.05 |
| 07/22/2021 | Q2 | -- | -- | $1.60 | $1.43 | $0.17 |
| 04/27/2021 | Q1 | -- | -- | $1.91 | $1.71 | $0.20 |
| 01/28/2021 | Q4 | -- | -- | $0.73 | $1.12 | -$0.39 |
| 10/29/2020 | Q3 | -- | -- | $0.62 | $0.72 | -$0.10 |
| 07/30/2020 | Q2 | -- | -- | $1.12 | $1.13 | -$0.01 |
| 04/30/2020 | Q1 | -- | -- | $1.48 | $1.56 | -$0.08 |
| 01/30/2020 | Q4 | -- | -- | $0.76 | $1.18 | -$0.42 |
| 10/29/2019 | Q3 | -- | -- | $0.59 | $0.70 | -$0.11 |
| 07/30/2019 | Q2 | -- | -- | $0.65 | $1.13 | -$0.48 |
| 04/25/2019 | Q1 | -- | -- | $1.40 | $1.45 | -$0.05 |
| 01/31/2019 | Q4 | -- | -- | $0.30 | $1.04 | -$0.74 |
| 10/25/2018 | Q3 | -- | -- | $0.54 | $0.74 | -$0.20 |
| 07/26/2018 | Q2 | -- | -- | $1.04 | -- | -- |
| 04/26/2018 | Q1 | -- | -- | $1.34 | -- | -- |
| 02/01/2018 | Q4 | -- | -- | $0.06 | -- | -- |
| 10/26/2017 | Q3 | -- | -- | $0.76 | -- | -- |
| 07/27/2017 | Q2 | -- | -- | $0.96 | -- | -- |
| 04/27/2017 | Q1 | -- | -- | $1.09 | -- | -- |
| 02/02/2017 | Q4 | -- | -- | $0.84 | -- | -- |
| 10/25/2016 | Q3 | -- | -- | $0.73 | -- | -- |
| 07/28/2016 | Q2 | -- | -- | $0.90 | -- | -- |
| 04/28/2016 | Q1 | -- | -- | $0.91 | -- | -- |
| 02/04/2016 | Q4 | -- | -- | $0.71 | -- | -- |
| 10/27/2015 | Q3 | -- | -- | $0.61 | -- | -- |
| 07/28/2015 | Q2 | -- | -- | $0.77 | -- | -- |
| 04/30/2015 | Q1 | -- | -- | $0.88 | -- | -- |
| 02/06/2015 | Q4 | -- | -- | $0.54 | -- | -- |
Marsh & McLennan Companies Earnings Questions
-
How Much did Marsh & McLennan Companies Generate in Revenue Last Quarter?
Marsh & McLennan Companies reported $5.7B worth of top line sales in its most recent quarter.
-
Did Marsh & McLennan Companies Beat Earnings Last Quarter?
Marsh & McLennan Companies announced earnings per share of $1.51 which represents a miss of analyst forecast a $1.62 per share.
-
Is Marsh & McLennan Companies Profitable?
Marsh & McLennan Companies reported $2.3B that represents $4.55 per share over the last quarter.
-
What is the Analyst Consensus for Marsh & McLennan Companies EPS Next Year?
Marsh & McLennan Companies's earnings are forecast to grow from $7.53 per share to $7.91 per share next year representing an increase of 15.82%.
-
When is Marsh & McLennan Companies's Earnings Date?
Marsh & McLennan Companies's next earnings date is January 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 4.33% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 5.28% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 2.28% over the past day.
